Thus, unveiling the mechanisms of glucose metabolism disruption that underlie APP up-regulation in the sporadic form of AD is a task of current concern in medicine and biology as a precursor to identifying risk factors for disease development and detecting new, alternative targets (other than amyloids) for therapeutic effect. Here, APP is linked to Alzheimer disease.